From the Journals
Examining Coprescription Trends Driving the Twin Epidemic
-
By
February 21, 2025
-
3 min
-
1
Longitudinal study on coprescription of opioids and stimulants
-
2
Association between stimulant use and opioid dosage escalation
-
3
Regional variations in opioid prescriptions and morphine milligram equivalent (MME)
-
4
Gender-based differences in opioid use
-
5
Need for targeted interventions and policy changes
-
A recent longitudinal cohort study investigated national trends in coprescription of opioids and stimulants, finding an association between stimulant use and opioid dosage escalation. Patients receiving stimulant prescriptions before their first opioid prescription had significantly higher odds of escalating opioid dose trajectories, highlighting the emerging 'twin epidemic' of opioid and stimulant misuse in the U.S. health care system. The study emphasizes the need for targeted interventions and policy changes to regulate coprescriptions and mitigate the risk of adverse outcomes.
-
1
Longitudinal study on coprescription of opioids and stimulants
-
2
Association between stimulant use and opioid dosage escalation
-
3
Regional variations in opioid prescriptions and morphine milligram equivalent (MME)
-
4
Gender-based differences in opioid use
-
5
Need for targeted interventions and policy changes
Listen Tab content
